Expand MREO Menu
MREO MENU

MREO Stock Summary and Trading Ideas (Mereo Biopharma Group PLC - American Depositary Shares | NASDAQ:MREO)

Charts for Today's Stock Price and Implied Volatility in Mereo Biopharma Group PLC - American Depositary Shares

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for MREO by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Mereo Biopharma Group PLC - American Depositary Shares (MREO) Frequently Asked Questions

What does Mereo Biopharma Group PLC - American Depositary Shares do?

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

What symbol and exchange does Mereo Biopharma Group PLC - American Depositary Shares shares trade?

Mereo Biopharma Group PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol MREO.

What is Mereo Biopharma Group PLC - American Depositary Shares stock price doing today?

As of August 19, 2026, MREO stock price was flat at $0.31 with 980,809 million shares trading.

What is Mereo Biopharma Group PLC - American Depositary Shares's Beta?

MREO has a beta of 2.79, meaning it tends to be more sensitive to market movements. MREO has a correlation of 0.04 to the broad based SPY ETF.

How much is Mereo Biopharma Group PLC - American Depositary Shares worth?

MREO has a market cap of $49.72 million. This is considered a Sub-Micro Cap stock.

How much money does Mereo Biopharma Group PLC - American Depositary Shares make?

Last quarter Mereo Biopharma Group PLC - American Depositary Shares reported $0 in Revenue and -$.01 earnings per share. This fell short of revenue expectation by $-863,830 and met earnings estimates .

What is the highest and lowest price Mereo Biopharma Group PLC - American Depositary Shares traded in the last 3 year period?

In the last 3 years, MREO traded as high as $5.02 and as low as $.20.

What are the top ETFs holding Mereo Biopharma Group PLC - American Depositary Shares?

The top ETF exchange traded funds that MREO belongs to (by Net Assets): GWX.

Is Mereo Biopharma Group PLC - American Depositary Shares (MREO) a good investment?

MREO has underperformed the market in the last year with a price return of -81.5% while the SPY ETF gained +20.7%. However, in the short term, MREO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +31.2% vs +4.4% return in SPY. But in the last 2 weeks, MREO shares have been beat by the market, returning -3.3% compared to an SPY return of -0.3%.

What are the support and resistance levels for Mereo Biopharma Group PLC - American Depositary Shares (MREO)?

MREO support price is $.30 and resistance is $.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MREO shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes